Sinensis Life Sciences Overview
- Founded
- 2012
- Status
- Acquired/Merged
- Employees
- 150
- Latest Deal Type
- M&A
Sinensis Life Sciences General Information
Description
Provider of pharmaceutical product testing and cGMP Quality Control (QC) services. The company Provides laboratory testing and manufacturing services for the international life sciences industry.
Contact Information
Website
Formerly Known As
PROXY Laboratories
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Pharmaceuticals
Acquirer
Primary Office
- Archimedesweg 23
- 2333 Leiden
- Netherlands
Sinensis Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 12-Jan-2016 | Completed | Startup | |||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Platform Creation | 17-Dec-2012 | Completed | Startup |
Sinensis Life Sciences Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of pharmaceutical product testing and cGMP Quality Control (QC) services. The company Provides laboratory testi
Laboratory Services (Healthcare)
Leiden, Netherlands
150
As of 2016
000000&0
000
tation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
000000000 00000 (0000000000)
Teddington, United Kingdom
0000
As of 0000
00000
000000000
0000000
re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
0000 000000000
Arlesheim, Switzerland
000000 - 000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSinensis Life Sciences Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LGC | Private Equity-Backed | Teddington, United Kingdom | 0000 | 00000 | 000000000 | |
| 0000000 | Formerly VC-backed | Arlesheim, Switzerland | 000000 - 000 | |||
| 00000 00000000 | Private Equity-Backed | Nashville, TN | 00000 | 000000000 | 00000 |
Sinensis Life Sciences Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ruud Santing Ph.D | Chief Executive Officer | ||
| Ruud Ardon | Chief Financial Officer |
Sinensis Life Sciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSinensis Life Sciences Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Jonghoud International | Family Office | Minority | 000 0000 | 000000 0 | |
| PROXY Laboratories | Corporation | 000 0000 | 000000 0 | ||
| Prolepha | Corporation | 000 0000 | 000000 0 |
Sinensis Life Sciences Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 00000 | 19-Sep-2014 | 000000000000000000 | Other Commercial Services | ||
| 00000000 | 31-Jan-2013 | 000000 00 000000 | Laboratory Services (Healthcare) | ||
| ProBase Pharma | 01-Jan-2012 | Joint Venture | Laboratory Services (Healthcare) |
Sinensis Life Sciences Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 000000 | 01-Jan-2012 | 00000 0000000 | Completed |
|